MiMedx Director Acquires $185K in Stock Through Annual Grant Program
MiMedx Group director Tiffany Olson received an annual restricted stock grant of 28,609 shares on June 18, 2025, at a price of $6.47 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MiMedx Group director Tiffany Olson received an annual restricted stock grant of 28,609 shares on June 18, 2025, at a price of $6.47 per share. Following this transaction, Olson's direct ownership increased to 57,597 shares.
Key details of the grant:
- Transaction was filed as an exempt grant under Rule 16b-3
- Vesting occurs at the earlier of 12 months or next annual shareholder meeting
- Grant is part of standard non-employee director compensation
- Transaction was executed through attorney-in-fact William F. Hulse
This Form 4 filing represents routine board compensation and indicates continued alignment between director and shareholder interests through equity-based compensation.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 28,609 | $6.47 | $185K |
Footnotes (1)
- F1. Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the vesting period for MDXG's director stock grants in 2025?
Was MDXG Director Tiffany Olson's stock acquisition made under Rule 10b5-1?
AI-generated analysis. How Rhea-AI works. Not financial advice.